MARTHA BOULTON: Open Payments
NPI 1538255880 · WESTPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 8 payments from 8 companies in 2025. Trend: 2023 $1,317 · 2024 $1,193 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $113 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
| Neurocrine BioSciences, Inc. | 1 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $104 |
Products named: FANAPT, KISUNLA, Auvelity, VRAYLAR, SPRAVATO, UZEDY, INGREZZA, CAPLYTA.
Industry payments across CT — which companies pay providers there.
